Jan 23, 2023 • 7:00 AM EST Matinas BioPharma to Provide Corporate Update and 2023 Business Outlook on January 30, 2023
Jan 12, 2023 • 7:00 AM EST Matinas BioPharma Announces Collaboration with National Resilience to Explore and Evaluate Novel LNC Platform Delivery Technology for Certain Nucleic Acids